Antheia, Inc.

📍 Menlo Park, United States🗓 Founded 2015👥 63 employees💰 Last funded Mar 2015
Biotechnology Research🌐 antheia.bio
Website LinkedIn
Antheia is the next-generation pharmaceutical ingredient producer with a mission to end drug shortages. Using advanced biosynthesis and fermentation technology, Antheia’s biomanufacturing platform enables rapid, efficient, agile, and on-demand production of key starting materials (KSMs) and active pharmaceutical ingredients (APIs) that are critical to public health. This highly flexible approach supports the needs of a growing society and improves global access to essential medicines. Founded in 2015, Antheia has grown into a commercial stage company with its first product to market, an active customer pipeline, and near-term product launches. For more information on how Antheia is transforming pharmaceutical supply chains, visit www.antheia.bio.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2015
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Antheia, Inc.?
Antheia, Inc. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Antheia, Inc. last raise funding?
The most recent investment in Antheia, Inc. recorded on gritt.io was in March 2015.
When was Antheia, Inc. founded?
Antheia, Inc. was founded in 2015.
What industry is Antheia, Inc. in?
Antheia, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Antheia, Inc. based?
Antheia, Inc. is headquartered in Menlo Park, United States.